Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: Cardiol Young. 2020 May 8;30(6):807–817. doi: 10.1017/S1047951120001018

Table 2.

Estimated cost savings associated with registry utilisation versus standard trial design, as a function of study size and other key trial characteristics, assuming registry data accessed locally.

Cost savings
(95% CI)
10,000
data elements
Study size*
100,000
data elements
1,000,000
data elements
Research coordinator time per data element
½ minute $−613 (−$20,512 to $15,904) $4547 (−$17,676 to $34,849) $522,050 ($35,922–1,946,536)
1½ minutes $9,864 (−$15,421 to $54,562) $152,314 ($4363–591,657) $1,576,810 ($113,08–5,847,937)
5 minutes $46,828 (−$6,674 to $193,799) $522,050 ($31,799–1,988,146) $5,248,845 ($384,909–19,425,286)
# of centres
1 $15,532 ($1,903–57,100) $157,982 ($11,327–575,888) $1,584,478 ($114,378–5,762,109)
10 $9864 (−$2,120 to $50,753) $152,314 ($4363–591,657) $1,576,810 ($110,353–$5,756,799)
200 −$109,790 (−$131,148 to −$72,972) $32,660 (−$69,542 to $425,076) $1,457,156 ($82,468–5,573,837)
% data abstracted from registry
1 −$4635 (−$4,846 to −$2,216) −$3052 (−$4370 to $2,227) $12,776 ($−4387 to $63,527)
90 $9864 ($1014–35,040) $152,314 ($4363–591,657) $1,576,810 ($107,742–5,850,295)
100 $11,493 ($1941–40,432) $169,771 ($12,445–632,672 $1,752,745 ($123,501–6,481,290)
Research coordinator salary
$29,407 $2310 ($734–8018) $75,041 ($5147–280,119) $802,351 ($57,089–2,893,852)
$57,596 $9864 ($1182–37,485) $152,314 ($4363–591,657) $1,576,810 ($114,226–5,674,802)
$117,528 $25,925 ($2010–99,466) $316,602 ($21,551–1,152,697) $3,223,370 ($236,132–11,586,442)
% of data requiring manual validation
0.1 $10,237 ($1280–39,175) $155,449 ($10,218–579,240) $1,607,563 ($113,372–5,853,231)
2 $9864 ($1068–38,643) $152,314 ($4363–591,657) $1,576,810 ($109,967–5,754,198)
5 $9275 ($870–37,738) $147,365 ($8738–555,247) $1,528,254 ($105,710–5,595,522)
Wage index, standard trial design**
0.5 $2170 ($539–8089) $73,395 ($4597–279,521) $785,644 ($53,629–2,877,068)
1 $9864 ($1113–38,582) $152,314 ($4363–591,657) $1,576,810 ($110,353–5,756,798)
1.5 $17,558 ($1768–69,244) $231,233 ($14,889–858,067) $2,367,976 ($167,109–8,637,726)
Fringe rate
0.2 $7892 ($909–31,124) $121,851 ($7827–459,078) $1,261,449 ($88,296–4,635,207)
0.5 $9864 ($1134–39,020 $152,314 ($4363–591,657) $1,576,810 ($110,371 to $5,794,010)
0.7 $11,180 ($1384–44,222) $172,622 ($11,088–650,361) $1,787,051 ($125,087–6,566,543)
# software platforms
1 $9864 ($1094–38,582) $152,314 ($4363–591,657) $1,576,810 ($110,352–5,756,799)
20 $2573 (−$3555 to $30,199) $145,023 ($3660–561,827) $1,569,519 ($103,076–5,748,996)
100 −$28,129 (−$18,702 to −$9,852) $114,321 (−$14,443 to $526,209) $1,538,817 ($75,754–5,716,833)
Indirect rate
0.5 $8704 ($989–37,035) $134,395 ($8558–508,693) $1,391,303 ($97,015–5,085,144)
0.7 $9864 ($1121–38,593) $152,314 ($4363–591,657) $1,576,810 ($109,951–5,763,163)
0.9 $11,024 ($1250–43,133) $170,234 ($10,839–636,745) $1,762,318 ($122,886–6,441,183)
Registry personnel experience level***
0.7 $9864 ($1113–38,583) $152,314 ($4363–591,657) $1,576,810 ($110,352–5,756,799)
5 $14,374 ($3358–49,401) $156,924 ($12,531–575,122) $1,581,320 ($114,201–5,762,129)
10 $15,191 ($3855–50,951) $157,641 ($13,092–575,700) $1,582,137 ($114,888–5,762,609)
Wage index, registry-based trial design**
0.5 $12,626 ($1217–49,615) $155,076 ($10,114–572,914) $1,579,572 ($111,907–5,760,444)
1 $9864 ($1113–$38,582) $152,314 ($4363–591,657) $1,576,810 ($110,352–5,756,799)
1.5 $7102 ($1079–23,315) $149,553 ($9306–564,946) $1,574,049 ($108,700–5,754,717)

Cost savings are calculated varying two study characteristics at a time and holding all other characteristics at base case values defined in Table 1.

*

Study size = number of total data elements (# of patients * # of discrete variables)

**

Wage index = a multiplier of base case salaries for a specific trial design’s personnel that accounts for regional or other variations in salary.

***

Experience = a multiplier of time to conduct each component of a registry-based trial; time decreases with prior experience with registry-based trials.